Mirion Q1 2026 Revenue and Guidance Clarifications
This discussion clarifies Mirion’s revenue guidance for FY2027, emphasizing that no incremental M&A is included in the forecast, with any acquisitions considered upside potential.
Read postDetailed company information
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
Last Updated: Sep 2026
Earnings Transcript for 2026 - Q2Released: Jul 29, 2026
Earnings Transcript for 2026 - Q1Released: Apr 29, 2026
Earnings Transcript for 2025 - Q4Released: Feb 11, 2026
Earnings Transcript for 2025 - Q3Released: Oct 29, 2025
Earnings Transcript for 2025 - Q2Released: Aug 01, 2025
Earnings Transcript for 2025 - Q1Released: Apr 30, 2025
Earnings Transcript for 2024 - Q4Released: Feb 12, 2025
Earnings Transcript for 2024 - Q3Released: Oct 30, 2024
Earnings Transcript for 2024 - Q2Released: Aug 02, 2024
Earnings Transcript for 2024 - Q1Released: May 01, 2024
Earnings Transcript for 2023 - Q4Released: Feb 14, 2024
Earnings Transcript for 2023 - Q3Released: Nov 02, 2023
Earnings Transcript for 2023 - Q2Released: Aug 02, 2023
Earnings Transcript for 2023 - Q1Released: May 04, 2023
Earnings Transcript for 2022 - Q4Released: Feb 14, 2023
Earnings Transcript for 2022 - Q3Released: Nov 01, 2022
Earnings Transcript for 2022 - Q2Released: Jul 29, 2022
Earnings Transcript for 2022 - Q1Released: May 04, 2022
Earnings Transcript for 2021 - Q4Released: Feb 23, 2022
Earnings Transcript for 2021 - Q3Released: Nov 12, 2021
GRC The Gorman-Rupp Company
This discussion clarifies Mirion’s revenue guidance for FY2027, emphasizing that no incremental M&A is included in the forecast, with any acquisitions considered upside potential.
Read postThis analysis provides a comprehensive overview of Mirion’s latest revenue performance in Q1 2026, highlighting competitive strategies, market conditions, and growth outlooks.
Read postMirion Technologies reported a total revenue of $258 million for Q1 2026, highlighting its recent financial performance.
Read postMirion Technologies reported a robust first quarter of 2026 with total revenues reaching $258 million, indicating strong market demand and operational growth.
Read post